🧬 SinoBioData Academic Portal
🏛️ Indexed Academic JournalOriginal: 中国新药杂志

Chinese Journal of New Drugs

Premier Chinese Biomedical Journal indexed in SinoBioData: Chinese Journal of New Drugs (中国新药杂志).

Total Research Papers: 200
Access: 100% Free Open Access
Browse by Publication Year & VolumeReset All Filters ✕

Published Research PapersFiltered: Year 2025 • Vol. 15

Showing 3 of 200 peer-reviewed papers with full Graphical Abstracts.

Original ResearchVol. 15, Issue 3 • pp. 1234-1245DOI: 10.1007/s12345-024-56789-0

A Novel Approach for the Reconstruction of 3D Models from Medical Images Using Deep Learning

Authors: John Doe, Jane Smith, Robert Johnson

This paper presents a novel deep learning framework for the reconstruction of three-dimensional (3D) models from two-dimensional (2D) medical images. The proposed method integrates convolutional neural networks (CNNs) with generative adversarial networks (GANs) to enhance the accuracy and efficiency of 3D reconstruction from CT and MRI scans. We evaluate our approach on a diverse dataset of medical images, demonstrating significant improvements over existing methods in terms of reconstruction quality, computational efficiency, and robustness to noise. Our results indicate that the proposed framework can effectively capture complex anatomical structures, making it a valuable tool for clinical diagnosis, surgical planning, and medical education. The study also discusses potential applications and future directions for research in this area.

A Novel Approach for the Reconstruction of 3D Models from Medical Images Using Deep Learning
Graphical Abstract
Original ResearchVol. 15, Issue 3 • pp. 123-135DOI: 10.1007/s12345-024-00001-2

A Study on the Application of Metformin in the Treatment of Type 2 Diabetes Mellitus

Authors: John Doe, Jane Smith, Robert Johnson

Background: Metformin is a first-line medication for type 2 diabetes mellitus (T2DM). This study evaluates its efficacy and safety in a cohort of patients. Methods: A retrospective analysis was conducted on 500 patients treated with metformin for 12 months. Results: Significant reductions in HbA1c and fasting blood glucose were observed. Adverse events were mild and gastrointestinal in nature. Conclusion: Metformin remains an effective and safe option for T2DM management.

A Study on the Application of Metformin in the Treatment of Type 2 Diabetes Mellitus
Graphical Abstract
Original ResearchVol. 15, Issue 3 • pp. 123-135DOI: 10.1000/1234-5678

Vaccine Adjuvants: Current Status and Future Directions

Authors: John Doe, Jane Smith, Robert Johnson

Vaccine adjuvants are critical components in enhancing and modulating immune responses to antigens. This review provides a comprehensive overview of the current status and future directions of vaccine adjuvants, focusing on their mechanisms of action, safety profiles, and applications in infectious disease and cancer vaccines. We discuss the challenges in adjuvant development, including the need for novel formulations that can induce robust and durable immunity with minimal reactogenicity. The paper highlights recent advances in adjuvant technology, such as the use of nanoparticles and toll-like receptor agonists, and emphasizes the importance of rational adjuvant design in the development of next-generation vaccines.

Vaccine Adjuvants: Current Status and Future Directions
Graphical Abstract